These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
|
|||||||||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||||||||
|
|
|
|||||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
|
|
|
|
||||||||||||
|
|
|
|
||||||||||||
|
|
|
|
||||||||||||
|
|
☒ | No | ☐ | |||||||||||||||||
|
|
☒ | No | ☐ | |||||||||||||||||
|
|
☒ | Accelerated Filer | ☐ | |||||||||||||||||
| Non-Accelerated Filer | ☐ | Smaller Reporting Company |
|
|||||||||||||||||
| Emerging Growth Company |
|
|||||||||||||||||||
| Yes |
|
No | ☒ | |||||||||||||||||
| Class |
Outstanding as of October 23, 2025
|
|||||||||||||
|
Corning’s Common Stock, $0.50 par value per share
|
|
|||||||||||||
| Page | |||||
|
Consolidated Statements of Income (Loss)
|
Corning Incorporated and Subsidiary Companies | ||||
| (Unaudited; in millions, except per share amounts) | |||||
|
Three months ended
September 30, |
Nine months ended
September 30, |
||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Cost of sales |
|
|
|
|
|||||||||||||||||||
| Gross margin |
|
|
|
|
|||||||||||||||||||
| Operating expenses: | |||||||||||||||||||||||
| Selling, general and administrative expenses |
|
|
|
|
|||||||||||||||||||
| Research, development and engineering expenses |
|
|
|
|
|||||||||||||||||||
| Amortization of purchased intangibles |
|
|
|
|
|||||||||||||||||||
| Operating income |
|
|
|
|
|||||||||||||||||||
| Interest income |
|
|
|
|
|||||||||||||||||||
| Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Translated earnings contract gain (loss), net (Note 11) |
|
(
|
|
(
|
|||||||||||||||||||
| Other expense, net |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Income (loss) before income taxes |
|
(
|
|
|
|||||||||||||||||||
| Provision for income taxes (Note 13) |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Net income (loss) |
|
(
|
|
|
|||||||||||||||||||
| Net income attributable to non-controlling interest |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Net income (loss) attributable to Corning Incorporated | $ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||
| Earnings (loss) per common share available to common shareholders: | |||||||||||||||||||||||
| Basic (Note 15) | $ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||
| Diluted (Note 15) | $ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||
| Consolidated Statements of Comprehensive Income | Corning Incorporated and Subsidiary Companies | ||||
| (Unaudited; in millions) | |||||
|
Three months ended
September 30, |
Nine months ended
September 30, |
||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Net income (loss) | $ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||
| Foreign currency translation adjustments and other (Note 14) |
(
|
|
|
|
|||||||||||||||||||
| Unamortized (losses) gains and prior service costs for postretirement benefit plans |
(
|
(
|
(
|
|
|||||||||||||||||||
| Realized and unrealized gains (losses) on derivatives |
|
(
|
|
(
|
|||||||||||||||||||
| Other comprehensive (loss) income, net of tax |
(
|
|
|
|
|||||||||||||||||||
| Comprehensive income |
|
|
|
|
|||||||||||||||||||
| Comprehensive income attributable to non-controlling interest |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Comprehensive income attributable to Corning Incorporated | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Consolidated Balance Sheets | Corning Incorporated and Subsidiary Companies | ||||
| (Unaudited; in millions, except share and per share amounts) | |||||
|
September 30,
2025 |
December 31,
2024 |
||||||||||
| Assets | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
|||||||
|
Trade accounts receivable, net of doubtful accounts - $
|
|
|
|||||||||
| Inventories (Note 5) |
|
|
|||||||||
| Other current assets |
|
|
|||||||||
| Total current assets |
|
|
|||||||||
|
Property, plant and equipment, net of accumulated depreciation - $
|
|
|
|||||||||
| Goodwill |
|
|
|||||||||
| Other intangible assets, net |
|
|
|||||||||
| Deferred income taxes (Note 13) |
|
|
|||||||||
| Other assets |
|
|
|||||||||
| Total Assets | $ |
|
$ |
|
|||||||
| Liabilities and Equity | |||||||||||
| Current liabilities: | |||||||||||
| Current portion of long-term debt and short-term borrowings (Note 8) | $ |
|
$ |
|
|||||||
| Accounts payable |
|
|
|||||||||
| Other accrued liabilities (Notes 7 and 10) |
|
|
|||||||||
| Total current liabilities |
|
|
|||||||||
| Long-term debt (Note 8) |
|
|
|||||||||
| Postretirement benefits other than pensions (Note 9) |
|
|
|||||||||
| Other liabilities (Notes 7 and 10) |
|
|
|||||||||
| Total liabilities |
|
|
|||||||||
| Commitments and contingencies (Note 10) |
|
|
|||||||||
| Shareholders’ equity: (Note 14) | |||||||||||
|
Common stock – Par value $
Shares issued:
|
|
|
|||||||||
| Additional paid-in capital – common stock |
|
|
|||||||||
| Retained earnings |
|
|
|||||||||
|
Treasury stock, at cost; Shares held:
|
(
|
(
|
|||||||||
| Accumulated other comprehensive loss |
(
|
(
|
|||||||||
| Total Corning Incorporated shareholders’ equity |
|
|
|||||||||
| Non-controlling interest |
|
|
|||||||||
| Total equity |
|
|
|||||||||
| Total Liabilities and Equity | $ |
|
$ |
|
|||||||
| Consolidated Statements of Cash Flows | Corning Incorporated and Subsidiary Companies | ||||
| (Unaudited; in millions) | |||||
|
Nine months ended
September 30, |
|||||||||||
| 2025 | 2024 | ||||||||||
| Cash Flows from Operating Activities: | |||||||||||
| Net income | $ |
|
$ |
|
|||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Depreciation |
|
|
|||||||||
| Amortization of purchased intangibles |
|
|
|||||||||
| Loss on disposal of assets, net |
|
|
|||||||||
| Share-based compensation expense |
|
|
|||||||||
| Translation loss (gain) on foreign denominated debt, net |
|
(
|
|||||||||
| Deferred tax benefit |
(
|
(
|
|||||||||
| Translated earnings contract (gain) loss, net |
(
|
|
|||||||||
| Release of cumulative translation losses |
|
|
|||||||||
| Changes in assets and liabilities: | |||||||||||
| Trade accounts receivable |
(
|
(
|
|||||||||
| Inventories |
(
|
(
|
|||||||||
| Other current assets |
(
|
(
|
|||||||||
| Accounts payable and other current liabilities |
|
|
|||||||||
| Customer deposits and government incentives |
(
|
|
|||||||||
| Deferred income |
(
|
|
|||||||||
| Other, net |
|
|
|||||||||
| Net cash provided by operating activities |
|
|
|||||||||
| Cash Flows from Investing Activities: | |||||||||||
| Capital expenditures |
(
|
(
|
|||||||||
| Realized gains on translated earnings contracts and other |
|
|
|||||||||
| Other, net |
(
|
(
|
|||||||||
| Net cash used in investing activities |
(
|
(
|
|||||||||
| Cash Flows from Financing Activities: | |||||||||||
| Repayments of debt |
(
|
(
|
|||||||||
| Proceeds from issuance of debt |
|
|
|||||||||
| Repayment of acquisition related debt |
(
|
|
|||||||||
| Proceeds from cross currency swap |
|
|
|||||||||
| Payments of employee withholding tax on stock awards |
(
|
(
|
|||||||||
| Proceeds from exercise of stock options |
|
|
|||||||||
| Purchases of common stock for treasury |
(
|
(
|
|||||||||
| Dividends paid |
(
|
(
|
|||||||||
| Other, net |
(
|
(
|
|||||||||
| Net cash used in financing activities |
(
|
(
|
|||||||||
| Effect of exchange rates on cash |
|
(
|
|||||||||
| Net decrease in cash and cash equivalents |
(
|
(
|
|||||||||
| Cash and cash equivalents at beginning of period |
|
|
|||||||||
| Cash and cash equivalents at end of period | $ |
|
$ |
|
|||||||
| Consolidated Statements of Changes in Shareholders’ Equity | Corning Incorporated and Subsidiary Companies | ||||
| (Unaudited; in millions, except per share amounts) | |||||
| Common stock |
Additional paid-in capital
common |
Retained earnings | Treasury stock |
Accumulated other
comprehensive loss |
Total Corning Incorporated
shareholders’ equity
|
Non-controlling interest | Total | ||||||||||||||||||||||||||||||||||||||||
| Balance as of December 31, 2024 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Net income |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||
| Purchase of common stock for treasury |
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Shares issued to benefit plans and for option exercises |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
Common dividends ($
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
|
Other, net
(1)
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Balance as of March 31, 2025 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Net income |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
| Purchase of common stock for treasury |
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Shares issued to benefit plans and for option exercises |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
Common dividends ($
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
|
Other, net
(1)
|
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Balance as of June 30, 2025 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Net income |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss |
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Purchase of common stock for treasury |
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Shares issued to benefit plans and for option exercises |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
Other, net
(1)
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Balance as of September 30, 2025 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Common stock |
Additional paid-in capital
common |
Retained earnings | Treasury stock |
Accumulated other
comprehensive loss |
Total Corning Incorporated
shareholders’ equity
|
Non-controlling interest | Total | ||||||||||||||||||||||||||||||||||||||||
| Balance as of December 31, 2023 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Net income |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss |
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Shares issued to benefit plans and for option exercises |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
Common dividends ($
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
|
Other, net
(1)
|
(
|
(
|
|
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Balance as of March 31, 2024 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Net income |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss |
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Purchase of common stock for treasury |
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Shares issued to benefit plans and for option exercises |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
Common dividends ($
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
|
Other, net
(1)
|
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Balance as of June 30, 2024 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Net (loss) income |
(
|
(
|
|
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
| Purchase of common stock for treasury |
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||||
| Shares issued to benefit plans and for option exercises |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
Other, net
(1)
|
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Balance as of September 30, 2024 | $ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
|
Three months ended
September 30, |
Nine months ended
September 30, |
||||||||||||||||||||||
| 2024 | 2024 | ||||||||||||||||||||||
|
Severance
(1)
|
$ |
|
$ |
|
|||||||||||||||||||
|
Capacity realignment
(1)
|
|
|
|||||||||||||||||||||
|
Other charges and credits
(2)
|
|
|
|||||||||||||||||||||
| Total restructuring, impairment and other charges and credits | $ |
|
$ |
|
|||||||||||||||||||
| Inventories | $ |
|
|||
| Property, plant and equipment |
|
||||
| Accounts payable |
(
|
||||
|
Other net assets
(1)
|
|
||||
| Total identified net assets |
|
||||
| Fair value of purchase price consideration |
|
||||
|
Goodwill
(2)
|
$ |
|
|||
|
Three months ended
September 30, |
Nine months ended
September 30, |
||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Optical communications products | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Display products |
|
|
|
|
|||||||||||||||||||
| Specialty materials products |
|
|
|
|
|||||||||||||||||||
| Automotive products |
|
|
|
|
|||||||||||||||||||
| Life sciences products |
|
|
|
|
|||||||||||||||||||
| Polycrystalline silicon products |
|
|
|
|
|||||||||||||||||||
| All other products |
|
|
|
|
|||||||||||||||||||
| Total revenue | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
September 30,
2025 |
December 31,
2024 |
||||||||||
| Finished goods | $ |
|
$ |
|
|||||||
| Work in process |
|
|
|||||||||
| Raw materials and accessories |
|
|
|||||||||
| Supplies and packing materials |
|
|
|||||||||
| Inventories | $ |
|
$ |
|
|||||||
|
September 30,
2025 |
December 31,
2024 |
||||||||||
| Current liabilities: | |||||||||||
| Wages and employee benefits | $ |
|
$ |
|
|||||||
| Income taxes |
|
|
|||||||||
| Derivative instruments (Note 11) |
|
|
|||||||||
| Deferred revenue (Note 4) |
|
|
|||||||||
| Customer deposits (Note 4) |
|
|
|||||||||
| Short-term operating leases |
|
|
|||||||||
| Other current liabilities |
|
|
|||||||||
| Other accrued liabilities | $ |
|
$ |
|
|||||||
| Non-current liabilities: | |||||||||||
| Defined benefit pension plan liabilities | $ |
|
$ |
|
|||||||
| Derivative instruments (Note 11) |
|
|
|||||||||
| Deferred revenue (Note 4) |
|
|
|||||||||
| Customer deposits (Note 4) |
|
|
|||||||||
| Contingent consideration (Note 3) |
|
|
|||||||||
| Deferred tax liabilities |
|
|
|||||||||
| Long-term operating leases |
|
|
|||||||||
| Other non-current liabilities |
|
|
|||||||||
| Other liabilities | $ |
|
$ |
|
|||||||
| Pension benefits | Postretirement benefits | ||||||||||||||||||||||||||||||||||||||||||||||
|
Three months ended
September 30, |
Nine months ended
September 30, |
Three months ended
September 30, |
Nine months ended
September 30, |
||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||||||||||||||||||||
| Service cost | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
| Interest cost |
|
|
|
|
|
$ |
|
|
|
||||||||||||||||||||||||||||||||||||||
| Expected return on plan assets |
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Amortization of actuarial net gain |
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||
|
Amortization of prior service cost
(credit) |
|
|
|
|
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Recognition of actuarial gain |
|
(
|
|
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Special termination benefit charge |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||
| Total pension and postretirement benefit expense (income) | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||||||||||
| September 30, 2025 | December 31, 2024 | ||||||||||||||||||||||||||||||||||
| Notional amount |
Fair value asset
(1)
|
Fair value liability
(1)
|
Notional amount |
Fair value asset
(1)
|
Fair value liability
(1)
|
||||||||||||||||||||||||||||||
|
Derivatives designated as hedging instruments
(2)
:
|
|||||||||||||||||||||||||||||||||||
|
Foreign exchange and precious metals lease contracts
(3)
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||||||
| Derivatives not designated as hedging instruments: | |||||||||||||||||||||||||||||||||||
| Foreign exchange contracts |
|
|
(
|
|
|
(
|
|||||||||||||||||||||||||||||
|
Translated earnings contracts
(4)
|
|
|
(
|
|
|
(
|
|||||||||||||||||||||||||||||
| Cross currency swap contracts |
|
|
(
|
|
|
(
|
|||||||||||||||||||||||||||||
| Total derivatives | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||||||
| Current | $ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||||||||||
| Non-current |
|
(
|
|
(
|
|||||||||||||||||||||||||||||||
| Total derivatives | $ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||||||||||
|
September 30,
2025 |
December 31,
2024 |
||||||||||
| Forward contracts: | |||||||||||
| Japanese yen-denominated | $ |
|
$ |
|
|||||||
| South Korean won-denominated |
|
|
|||||||||
| Chinese yuan-denominated |
|
|
|||||||||
| New Taiwan dollar-denominated |
|
|
|||||||||
| Mexican peso-denominated |
|
|
|||||||||
| Euro-denominated |
|
|
|||||||||
| Option contracts: | |||||||||||
| Japanese yen-denominated |
|
|
|||||||||
| Euro-denominated |
|
|
|||||||||
| Total gross notional amount for translated earnings contracts | $ |
|
$ |
|
|||||||
| Three months ended September 30, | |||||||||||||||||||||||||||||
|
Gain (loss) recognized
in other comprehensive
income (loss) (OCI)
(1)
|
Location of gain
reclassified from accumulated OCI into income effective (ineffective) |
Gain reclassified
from accumulated OCI into income |
|||||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||||||
| Hedging relationships for cash flow, net investment and fair value hedges: | |||||||||||||||||||||||||||||
| Foreign exchange and precious metals lease contracts | $ |
|
$ |
(
|
Cost of sales | $ |
|
$ |
|
||||||||||||||||||||
| Other expense, net |
|
|
|||||||||||||||||||||||||||
| Total designated | $ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||||
| Nine months ended September 30, | |||||||||||||||||||||||||||||
|
Gain (loss) recognized
in other comprehensive
income (loss) (OCI)
(1)
|
Location of (loss) gain
reclassified from accumulated OCI into income effective (ineffective) |
(Loss) gain reclassified
from accumulated OCI into income |
|||||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||||||
| Hedging relationships for cash flow, net investment and fair value hedges: | |||||||||||||||||||||||||||||
| Foreign exchange and precious metals lease contracts | $ |
|
$ |
(
|
Cost of sales | $ |
(
|
$ |
|
||||||||||||||||||||
| Other expense, net |
|
(
|
|||||||||||||||||||||||||||
| Total designated | $ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||||||||
| (Loss) gain recognized in income (loss) | Location of gain (loss) recognized in income (loss) | ||||||||||||||||||||||||||||
|
Three months ended
September 30, |
Nine months ended
September 30, |
||||||||||||||||||||||||||||
| Undesignated derivatives | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||||
| Foreign exchange contracts | $ |
(
|
$ |
|
$ |
|
$ |
|
Other expense, net | ||||||||||||||||||||
|
Translated earnings contracts
(1)
|
|
(
|
|
(
|
Translated earnings contract gain (loss), net | ||||||||||||||||||||||||
| Cross currency swap contracts |
(
|
|
(
|
|
Other expense, net | ||||||||||||||||||||||||
| Total undesignated | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||||
|
Number
of shares (in thousands) |
Weighted
average grant-date fair value |
||||||||||
| Non-vested as of December 31, 2024 |
|
$ |
|
||||||||
| Granted |
|
|
|||||||||
| Vested |
(
|
|
|||||||||
| Forfeited |
(
|
|
|||||||||
| Non-vested as of September 30, 2025 |
|
$ |
|
||||||||
|
Number
of shares (in thousands) |
Weighted
average grant-date fair value |
||||||||||
| Non-vested as of December 31, 2024 |
|
$ |
|
||||||||
| Granted |
|
|
|||||||||
| Vested |
(
|
|
|||||||||
| Performance adjustments |
|
|
|||||||||
| Forfeited |
(
|
|
|||||||||
| Non-vested as of September 30, 2025 |
|
$ |
|
||||||||
|
Three months ended
September 30, |
Nine months ended
September 30, |
||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Provision for income taxes | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Effective tax rate |
|
% |
(
|
%) |
|
% |
|
% | |||||||||||||||
|
Three months ended
September 30, |
Nine months ended
September 30, |
||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Beginning balance | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
|
(Loss) gain on foreign currency translation
(1)
|
(
|
|
|
|
|||||||||||||||||||
|
Release of cumulative translation losses
(2)
|
|
|
|
|
|||||||||||||||||||
|
Equity method affiliates
(1)
|
(
|
|
|
|
|||||||||||||||||||
| Net current-period other comprehensive (loss) income, net of tax |
(
|
|
|
|
|||||||||||||||||||
| Ending balance | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
|
Three months ended
September 30, |
Nine months ended
September 30, |
||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Net income (loss) attributable to Corning Incorporated | $ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||
| Weighted-average common shares outstanding – basic |
|
|
|
|
|||||||||||||||||||
| Effect of dilutive securities: | |||||||||||||||||||||||
| Stock options and other awards |
|
|
|
|
|||||||||||||||||||
| Weighted-average common shares outstanding – diluted |
|
|
|
|
|||||||||||||||||||
| Basic earnings (loss) per common share | $ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||
| Diluted earnings (loss) per common share | $ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||
| Anti-dilutive potential shares excluded from diluted earnings (loss) per common share: | |||||||||||||||||||||||
| Stock options and other awards |
|
|
|
|
|||||||||||||||||||
| Currency | Japanese yen | South Korean won | Chinese yuan | New Taiwan dollar | Mexican peso | Euro | ||||||||||||||
| 2024 Rate |
¥
|
₩
|
¥
|
NT$
|
MX$
|
€
|
||||||||||||||
| 2025 Rate |
¥
|
₩
|
¥
|
NT$
|
MX$
|
€
|
||||||||||||||
|
Optical
Communications |
Display | Specialty Materials | Automotive |
Life
Sciences |
Hemlock and Emerging Growth Businesses | Total | |||||||||||||||||||||||||||||||||||
| Three months ended September 30, 2025 | |||||||||||||||||||||||||||||||||||||||||
| Segment net sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Less: | |||||||||||||||||||||||||||||||||||||||||
|
Research, development and
engineering expenses
(1)
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Depreciation
(2)
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Other segment items
(3)
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Income tax provision
(4)
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Segment net income (loss) | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Capital expenditures | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Three months ended September 30, 2024 | |||||||||||||||||||||||||||||||||||||||||
| Segment net sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Less: | |||||||||||||||||||||||||||||||||||||||||
|
Research, development and
engineering expenses
(1)
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Depreciation
(2)
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Other segment items
(3)
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Income tax provision
(4)
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Segment net income | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Capital expenditures | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Nine months ended September 30, 2025 | |||||||||||||||||||||||||||||||||||||||||
| Segment net sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Less: | |||||||||||||||||||||||||||||||||||||||||
|
Research, development and
engineering expenses
(1)
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Depreciation
(2)
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Other segment items
(3)
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Income tax provision
(4)
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Segment net income (loss) | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Capital expenditures | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Nine months ended September 30, 2024 | |||||||||||||||||||||||||||||||||||||||||
| Segment net sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Less: | |||||||||||||||||||||||||||||||||||||||||
|
Research, development and
engineering expenses
(1)
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Depreciation
(2)
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Other segment items
(3)
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
|
Income tax provision
(4)
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||
| Segment net income | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Capital expenditures | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
|
Optical
Communications |
Display | Specialty Materials | Automotive |
Life
Sciences |
Hemlock and Emerging Growth Businesses | Total | |||||||||||||||||||||||||||||||||||
| September 30, 2025 | |||||||||||||||||||||||||||||||||||||||||
|
Investment in affiliated companies,
at equity |
$ |
|
$ |
|
$ |
|
|
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||
|
Segment assets
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| December 31, 2024 | |||||||||||||||||||||||||||||||||||||||||
|
Investment in affiliated companies,
at equity |
$ |
|
$ |
|
$ |
|
|
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||
|
Segment assets
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
|
Three months ended
September 30, |
Nine months ended
September 30, |
||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Net sales of reportable segments | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Net sales of Hemlock and Emerging Growth Businesses |
|
|
|
|
|||||||||||||||||||
|
Impact of constant-currency reporting
(1)
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Consolidated net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Three months ended
September 30, |
Nine months ended
September 30, |
||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Net income of reportable segments | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Net (loss) income of Hemlock and Emerging Growth Businesses |
(
|
|
(
|
|
|||||||||||||||||||
| Unallocated amounts: | |||||||||||||||||||||||
| Impact of constant-currency reporting |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Translated earnings contract gain (loss), net |
|
(
|
|
(
|
|||||||||||||||||||
| Translation gain (loss) on foreign denominated debt, net |
|
(
|
(
|
|
|||||||||||||||||||
| Litigation, regulatory and other legal matters |
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
Research, development, and engineering expenses
(1)
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Amortization of intangibles |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Interest expense, net |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Income tax benefit |
|
|
|
|
|||||||||||||||||||
| Severance charges |
|
(
|
(
|
(
|
|||||||||||||||||||
|
Capacity optimization and other charges and credits
(2)
|
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Other corporate items |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Net income (loss) | $ |
|
$ |
(
|
$ |
|
$ |
|
|||||||||||||||
|
Three months ended
September 30, |
%
change |
Nine months ended
September 30, |
%
change |
||||||||||||||||||||||||||||||||
| 2025 | 2024 | 25 vs. 24 | 2025 | 2024 | 25 vs. 24 | ||||||||||||||||||||||||||||||
| Net sales | $ | 4,100 | $ | 3,391 | 21 | % | $ | 11,414 | $ | 9,617 | 19 | % | |||||||||||||||||||||||
| Cost of sales | $ | 2,580 | $ | 2,254 | 14 | % | $ | 7,288 | $ | 6,538 | 11 | % | |||||||||||||||||||||||
| Gross margin | $ | 1,520 | $ | 1,137 | 34 | % | $ | 4,126 | $ | 3,079 | 34 | % | |||||||||||||||||||||||
| Gross margin % | 37 | % | 34 | % | 36 | % | 32 | % | |||||||||||||||||||||||||||
| Selling, general and administrative expenses | $ | 624 | $ | 510 | 22 | % | $ | 1,610 | $ | 1,432 | 12 | % | |||||||||||||||||||||||
| as a % of net sales | 15 | % | 15 | % | 14 | % | 15 | % | |||||||||||||||||||||||||||
| Research, development and engineering expenses | $ | 280 | $ | 294 | (5 | %) | $ | 826 | $ | 814 | 1 | % | |||||||||||||||||||||||
| as a % of net sales | 7 | % | 9 | % | 7 | % | 8 | % | |||||||||||||||||||||||||||
|
Translated earnings contract gain (loss), net
|
$ | 33 | $ | (157) | * | $ | 63 | $ | (91) | * | |||||||||||||||||||||||||
| Income (loss) before income taxes | $ | 550 | $ | (92) | * | $ | 1,374 | $ | 376 | * | |||||||||||||||||||||||||
| Provision for income taxes | $ | 80 | $ | 3 | * | $ | 219 | $ | 124 | 77 | % | ||||||||||||||||||||||||
| Effective tax rate | 14.5 | % | (3.3 | %) | 15.9 | % | 33.0 | % | |||||||||||||||||||||||||||
|
Three months ended
September 30, 2025 |
Three months ended
September 30, 2024 |
Change
2025 vs. 2024
|
|||||||||||||||||||||||||||||||||
|
Income
before tax |
Net
income |
(Loss) income
before
tax
|
Net
loss
|
Income
before tax |
Net
income |
||||||||||||||||||||||||||||||
| Hedges related to translated earnings: | |||||||||||||||||||||||||||||||||||
|
Realized (loss) gain, net
(1) (2)
|
$ | (5) | $ | (4) | $ | 47 | $ | 36 | $ | (52) | $ | (40) | |||||||||||||||||||||||
|
Unrealized gain (loss), net
|
38 | 29 | (204) | (157) | 242 | 186 | |||||||||||||||||||||||||||||
|
Total translated earnings contract gain (loss), net
|
$ | 33 | $ | 25 | $ | (157) | $ | (121) | $ | 190 | $ | 146 | |||||||||||||||||||||||
|
Nine months ended
September 30, 2025 |
Nine months ended
September 30, 2024 |
Change
2025 vs. 2024
|
|||||||||||||||||||||||||||||||||
|
Income
before tax |
Net
income |
Income
before
tax
|
Net
income
|
Income
before tax |
Net
income |
||||||||||||||||||||||||||||||
| Hedges related to translated earnings: | |||||||||||||||||||||||||||||||||||
|
Realized gain, net
(1) (2)
|
$ | 2 | $ | 1 | $ | 158 | $ | 121 | $ | (156) | $ | (120) | |||||||||||||||||||||||
|
Unrealized gain (loss), net
|
61 | 47 | (249) | (191) | 310 | 238 | |||||||||||||||||||||||||||||
|
Total translated earnings contract gain (loss), net
|
$ | 63 | $ | 48 | $ | (91) | $ | (70) | $ | 154 | $ | 118 | |||||||||||||||||||||||
|
Three months ended
September 30, |
$
change |
%
change |
Nine months ended
September 30, |
$
change |
%
change |
||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | 25 vs. 24 | 25 vs. 24 | 2025 | 2024 | 25 vs. 24 | 25 vs. 24 | ||||||||||||||||||||||||||||||||||||||||
| Optical Communications | $ | 1,652 | $ | 1,246 | $ | 406 | 33 | % | $ | 4,573 | $ | 3,289 | $ | 1,284 | 39 | % | |||||||||||||||||||||||||||||||
| Display | 939 | 1,015 | (76) | (7 | %) | 2,742 | 2,901 | (159) | (5 | %) | |||||||||||||||||||||||||||||||||||||
| Specialty Materials | 621 | 548 | 73 | 13 | % | 1,667 | 1,503 | 164 | 11 | % | |||||||||||||||||||||||||||||||||||||
| Automotive | 454 | 430 | 24 | 6 | % | 1,354 | 1,400 | (46) | (3 | %) | |||||||||||||||||||||||||||||||||||||
| Life Sciences | 242 | 244 | (2) | (1 | %) | 726 | 729 | (3) | 0 | % | |||||||||||||||||||||||||||||||||||||
| Net sales of reportable segments | 3,908 | 3,483 | 425 | 12 | % | 11,062 | 9,822 | 1,240 | 13 | % | |||||||||||||||||||||||||||||||||||||
|
Hemlock and Emerging Growth
Businesses |
364 | 250 | 114 | 46 | % | 934 | 773 | 161 | 21 | % | |||||||||||||||||||||||||||||||||||||
|
Net sales of reportable segments and
Hemlock and Emerging Growth
Businesses
(1)
|
$ | 4,272 | $ | 3,733 | $ | 539 | 14 | % | $ | 11,996 | $ | 10,595 | $ | 1,401 | 13 | % | |||||||||||||||||||||||||||||||
|
Three months ended
September 30, |
$
change |
%
change |
Nine months ended
September 30, |
$
change |
%
change |
||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | 25 vs. 24 | 25 vs. 24 | 2025 | 2024 | 25 vs. 24 | 25 vs. 24 | ||||||||||||||||||||||||||||||||||||||||
| Optical Communications | $ | 295 | $ | 175 | $ | 120 | 69 | % | $ | 743 | $ | 418 | $ | 325 | 78 | % | |||||||||||||||||||||||||||||||
| Display | 250 | 285 | (35) | (12 | %) | 736 | 744 | (8) | (1 | %) | |||||||||||||||||||||||||||||||||||||
| Specialty Materials | 113 | 72 | 41 | 57 | % | 268 | 179 | 89 | 50 | % | |||||||||||||||||||||||||||||||||||||
| Automotive | 68 | 51 | 17 | 33 | % | 215 | 200 | 15 | 8 | % | |||||||||||||||||||||||||||||||||||||
| Life Sciences | 16 | 15 | 1 | 7 | % | 47 | 45 | 2 | 4 | % | |||||||||||||||||||||||||||||||||||||
| Net income of reportable segments | 742 | 598 | 144 | 24 | % | 2,009 | 1,586 | 423 | 27 | % | |||||||||||||||||||||||||||||||||||||
|
Hemlock and Emerging Growth
Businesses |
(1) | 12 | (13) | * | (27) | 32 | (59) | * | |||||||||||||||||||||||||||||||||||||||
|
Net income of reportable segments
and Hemlock and Emerging
Growth Businesses
(1)
|
$ | 741 | $ | 610 | $ | 131 | 21 | % | $ | 1,982 | $ | 1,618 | $ | 364 | 22 | % | |||||||||||||||||||||||||||||||
|
Three months ended
September 30, |
%
change |
Nine months ended
September 30, |
%
change |
||||||||||||||||||||||||||||||||
| 2025 | 2024 | 25 vs. 24 | 2025 | 2024 | 25 vs. 24 | ||||||||||||||||||||||||||||||
| Core net sales | $ | 4,272 | $ | 3,733 | 14 | % | $ | 11,996 | $ | 10,595 | 13 | % | |||||||||||||||||||||||
| Core net income | $ | 585 | $ | 465 | 26 | % | $ | 1,575 | $ | 1,202 | 31 | % | |||||||||||||||||||||||
| Core earnings per share | $ | 0.67 | $ | 0.54 | 24 | % | $ | 1.81 | $ | 1.38 | 31 | % | |||||||||||||||||||||||
|
Three months ended
September 30, |
Nine months ended
September 30, |
||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Core net income | $ | 585 | $ | 465 | $ | 1,575 | $ | 1,202 | |||||||||||||||
| Weighted-average common shares outstanding - basic | 856 | 854 | 855 | 853 | |||||||||||||||||||
| Effect of dilutive securities: | |||||||||||||||||||||||
| Stock options and other awards | 12 | 11 | 15 | 15 | |||||||||||||||||||
| Weighted-average common shares outstanding - diluted | 868 | 865 | 870 | 868 | |||||||||||||||||||
| Core earnings per share | $ | 0.67 | $ | 0.54 | $ | 1.81 | $ | 1.38 | |||||||||||||||
| Three months ended September 30, 2025 | |||||||||||||||||||||||||||||
| Net sales | Income before income taxes | Net income attributable to Corning Incorporated | Effective tax rate (a)(b) | Per Share | |||||||||||||||||||||||||
| As reported – GAAP | $ | 4,100 | $ | 550 | $ | 430 | 14.5 | % | $ | 0.50 | |||||||||||||||||||
|
Constant-currency adjustment
(1)
|
172 | 157 | 111 | 0.13 | |||||||||||||||||||||||||
|
Translation gain on foreign denominated debt, net
(2)
|
(4) | (4) | (0.00) | ||||||||||||||||||||||||||
|
Translated earnings contract gain, net
(3)
|
(33) | (25) | (0.03) | ||||||||||||||||||||||||||
|
Acquisition-related costs
(4)
|
30 | 22 | 0.03 | ||||||||||||||||||||||||||
|
Discrete tax items and other tax-related adjustments
(5)
|
(21) | (0.02) | |||||||||||||||||||||||||||
|
Restructuring, impairment and other charges and credits
(6)
|
16 | 12 | 0.01 | ||||||||||||||||||||||||||
|
Litigation, regulatory and other legal matters
(7)
|
50 | 50 | 0.06 | ||||||||||||||||||||||||||
|
Pension mark-to-market adjustment
(8)
|
12 | 9 | 0.01 | ||||||||||||||||||||||||||
|
Loss on investments
(9)
|
1 | 1 | 0.00 | ||||||||||||||||||||||||||
| Core performance measures | $ | 4,272 | $ | 779 | $ | 585 | 19.5 | % | $ | 0.67 | |||||||||||||||||||
| Three months ended September 30, 2024 | |||||||||||||||||||||||||||||
| Net sales | (Loss) income before income taxes | Net (loss) income attributable to Corning Incorporated | Effective tax rate (a)(b) | Per Share | |||||||||||||||||||||||||
| As reported - GAAP | $ | 3,391 | $ | (92) | $ | (117) | (3.3 | %) | $ | (0.14) | |||||||||||||||||||
|
Constant-currency adjustment
(1)
|
342 | 258 | 239 | 0.28 | |||||||||||||||||||||||||
|
Translation loss on foreign denominated debt, net
(2)
|
107 | 82 | 0.10 | ||||||||||||||||||||||||||
|
Translated earnings contract loss, net
(3)
|
157 | 121 | 0.14 | ||||||||||||||||||||||||||
|
Acquisition-related costs
(4)
|
32 | 23 | 0.03 | ||||||||||||||||||||||||||
|
Discrete tax items and other tax-related adjustments
(5)
|
(14) | (0.02) | |||||||||||||||||||||||||||
|
Restructuring, impairment and other charges and credits
(6)
|
134 | 125 | 0.15 | ||||||||||||||||||||||||||
|
Litigation, regulatory and other legal matters
(7)
|
16 | 12 | 0.01 | ||||||||||||||||||||||||||
|
Pension mark-to-market adjustment
(8)
|
(20) | (15) | (0.02) | ||||||||||||||||||||||||||
|
Loss on investments
(9)
|
7 | 7 | 0.01 | ||||||||||||||||||||||||||
|
Loss on sale of assets
(10)
|
3 | 2 | 0.00 | ||||||||||||||||||||||||||
| Core performance measures | $ | 3,733 | $ | 602 | $ | 465 | 19.1 | % | $ | 0.54 | |||||||||||||||||||
| Nine months ended September 30, 2025 | |||||||||||||||||||||||||||||
| Net sales | Income before income taxes | Net income attributable to Corning Incorporated | Effective tax rate (a)(b) | Per Share | |||||||||||||||||||||||||
| As reported - GAAP | $ | 11,414 | $ | 1,374 | $ | 1,056 | 15.9 | % | $ | 1.21 | |||||||||||||||||||
|
Constant-currency adjustment
(1)
|
582 | 496 | 404 | 0.46 | |||||||||||||||||||||||||
|
Translation loss on foreign denominated debt, net
(2)
|
66 | 50 | 0.06 | ||||||||||||||||||||||||||
|
Translated earnings contract gain, net
(3)
|
(63) | (48) | (0.06) | ||||||||||||||||||||||||||
|
Acquisition-related costs
(4)
|
89 | 65 | 0.07 | ||||||||||||||||||||||||||
|
Discrete tax items and other tax-related adjustments
(5)
|
(56) | (0.06) | |||||||||||||||||||||||||||
|
Restructuring, impairment and other charges and credits
(6)
|
10 | 8 | 0.01 | ||||||||||||||||||||||||||
|
Litigation, regulatory and other legal matters
(7)
|
57 | 55 | 0.06 | ||||||||||||||||||||||||||
|
Pension mark-to-market adjustment
(8)
|
27 | 21 | 0.02 | ||||||||||||||||||||||||||
|
Loss on sale of assets
(10)
|
5 | 4 | 0.00 | ||||||||||||||||||||||||||
|
Equity in losses of affiliated companies
(11)
|
12 | 9 | 0.01 | ||||||||||||||||||||||||||
|
Loss on sale of business
(12)
|
11 | 7 | 0.01 | ||||||||||||||||||||||||||
| Core performance measures | $ | 11,996 | $ | 2,084 | $ | 1,575 | 19.5 | % | $ | 1.81 | |||||||||||||||||||
| Nine months ended September 30, 2024 | |||||||||||||||||||||||||||||
| Net sales | Income before income taxes | Net income attributable to Corning Incorporated | Effective tax rate (a)(b) | Per Share | |||||||||||||||||||||||||
| As reported - GAAP | $ | 9,617 | $ | 376 | $ | 196 | 33.0 | % | $ | 0.23 | |||||||||||||||||||
|
Constant-currency adjustment
(1)
|
978 | 751 | 604 | 0.70 | |||||||||||||||||||||||||
|
Translation gain on foreign denominated debt, net
(2)
|
(28) | (21) | (0.02) | ||||||||||||||||||||||||||
|
Translated earnings contract loss, net
(3)
|
91 | 70 | 0.08 | ||||||||||||||||||||||||||
|
Acquisition-related costs
(4)
|
96 | 69 | 0.08 | ||||||||||||||||||||||||||
|
Discrete tax items and other tax-related adjustments
(5)
|
5 | 0.01 | |||||||||||||||||||||||||||
|
Restructuring, impairment and other charges and credits
(6)
|
263 | 248 | 0.29 | ||||||||||||||||||||||||||
|
Litigation, regulatory and other legal matters
(7)
|
11 | 8 | 0.01 | ||||||||||||||||||||||||||
|
Pension mark-to-market adjustment
(8)
|
(6) | (4) | (0.00) | ||||||||||||||||||||||||||
|
Loss on investments
(9)
|
19 | 18 | 0.02 | ||||||||||||||||||||||||||
|
Loss on sale of assets
(10)
|
13 | 9 | 0.01 | ||||||||||||||||||||||||||
| Core performance measures | $ | 10,595 | $ | 1,586 | $ | 1,202 | 20.4 | % | $ | 1.38 | |||||||||||||||||||
| Currency | Japanese yen | South Korean won | Chinese yuan | New Taiwan dollar | Mexican peso | Euro | ||||||||||||||
| 2024 Rate | ¥107 | ₩1,175 | ¥6.7 | NT$31 | MX$20 | €0.81 | ||||||||||||||
| 2025 Rate | ¥120 | ₩1,250 | ¥6.9 | NT$31 | MX$21 | €0.88 | ||||||||||||||
|
September 30,
2025 |
December 31,
2024 |
||||||||||
| Working capital | $ | 3,100 | $ | 3,073 | |||||||
| Current ratio | 1.6:1 | 1.6:1 | |||||||||
| Trade accounts receivable, net of doubtful accounts | $ | 2,509 | $ | 2,053 | |||||||
| Days sales outstanding | 55 | 53 | |||||||||
| Inventories | $ | 3,104 | $ | 2,724 | |||||||
| Inventory turns | 3.2 | 3.2 | |||||||||
|
Days payable outstanding
(1)
|
66 | 54 | |||||||||
| Long-term debt | $ | 7,407 | $ | 6,885 | |||||||
| Total debt | $ | 8,219 | $ | 7,211 | |||||||
| Total debt to total capital | 41 | % | 39 | % | |||||||
|
Nine months ended
September 30, |
|||||||||||
| 2025 | 2024 | ||||||||||
| Net cash provided by operating activities | $ | 1,643 | $ | 1,316 | |||||||
| Net cash used in investing activities | $ | (765) | $ | (537) | |||||||
| Net cash used in financing activities | $ | (1,020) | $ | (944) | |||||||
|
September 30,
2025 |
|||||
| Cash and cash equivalents | $ | 1,648 | |||
| Available credit capacity: | |||||
| U.S. dollar revolving credit facility | $ | 1,500 | |||
| Period |
Total number
of shares
purchased
(1)
|
Average
price paid
per share
(2)
|
Number of
shares purchased as part of publicly announced programs |
Approximate
dollar value of shares that may be purchased under the publicly announced programs |
|||||||||||||||||||
| July1-31, 2025 | 80,083 | $ | 52.63 | ||||||||||||||||||||
| August1-31, 2025 | 483,285 | 65.70 | 304,608 | ||||||||||||||||||||
| September1-30, 2025 | 73,547 | 72.60 | 69,364 | ||||||||||||||||||||
| Total | 636,915 | $ | 64.85 | 373,972 | $ | 2,977,667,420 | |||||||||||||||||
| (a) | Exhibits | ||||||||||
| Exhibit Number | Exhibit Name | ||||||||||
| 101.INS | Inline XBRL Instance Document | ||||||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | ||||||||||
| 101.CAL | Inline XBRL Taxonomy Calculation Linkbase Document | ||||||||||
| 101.LAB | Inline XBRL Taxonomy Label Linkbase Document | ||||||||||
| 101.PRE | Inline XBRL Taxonomy Presentation Linkbase Document | ||||||||||
| 101.DEF | Inline XBRL Taxonomy Definition Document | ||||||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | ||||||||||
| Corning Incorporated | ||||||||||||||
| (Registrant) | ||||||||||||||
| October 31, 2025 | /s/ Stefan Becker | |||||||||||||
| Date | Stefan Becker | |||||||||||||
| Senior Vice President and Corporate Controller | ||||||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|